Dr. Roy Perlis on esketamine as an option for treatment-resistant depression.

madman

Super Moderator

Dr. Roy Perlis is the director of the Center for Quantitative Health at Massachusetts General Hospital and a professor of psychiatry at Harvard Medical School. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. J. Kim and Others. Esketamine for Treatment-Resistant Depression — First FDA-Approved Antidepressant in a New Class. N Engl J Med 2019;381:1-4.
 

ExcelMale Newsletter Signup

Online statistics

Members online
6
Guests online
554
Total visitors
560

Latest posts

Beyond Testosterone Podcast

Back
Top